Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2025-12-26 @ 2:42 AM
Study NCT ID:
NCT03495102
Status:
COMPLETED
Last Update Posted:
2020-06-12
First Post:
2018-04-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-05
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-10
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-02
First Submit QC Date:
None
Study First Post Date:
2018-04-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-05-28
Results First Submit QC Date:
None
Results First Post Date:
2020-06-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-28
Last Update Post Date:
2020-06-12
Last Update Post Date Type:
ACTUAL